Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Exenatide implant - Vivani Medical

Next Previous
Drug Profile

Exenatide implant - Vivani Medical

Alternative Names: NPM-115; NPM-119

Latest Information Update: 16 Oct 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Nano Precision Medical
  • Developer Vivani Medical
  • Class Antihyperglycaemics; Obesity therapies; Peptides; Venoms
  • Mechanism of Action Glucagon-like peptide-1 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I Obesity; Type 2 diabetes mellitus

Most Recent Events

  • 21 Aug 2025 Vivani Medical completes the phase-I LIBERATE-1 trial in Type 2 diabetes mellitus and Obesity (In volunteers) in Australia (Intradermal) (NCT05670379)
  • 05 Aug 2025 Adverse events data from phase I LIBERATE-1™ trial in Obesity and Type 2 diabetes mellitus released by Vivani Medical
  • 13 Mar 2025 Vivani Medical completes enrolment in the phase I LIBERATE-1™ trial in Obesity and Type 2 diabetes mellitus in Australia (Intradermal)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top